Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice

Documenti analoghi

• Response to “ RE : Utility of Plasma Myostatin as a Predictive Biomarker for Post Intensive Care Syndrome in Patients With Sepsis”
  di: Ayaki Shirahata, et al.
  Pubblicazione: (2026)
• Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
  di: Daisuke Ito, et al.
  Pubblicazione: (2024)
• Periorbital Necrotizing Soft Tissue Infection Caused by Streptococcus pyogenes
  di: Yuko Ono, et al.
  Pubblicazione: (2025)
• Migration of a pericardial drainage catheter into the right main pulmonary artery
  di: Yuko Ono, et al.
  Pubblicazione: (2024)
• Roles of programmed death‐1 and muscle innate lymphoid cell‐derived interleukin 13 in sepsis‐induced intensive care unit‐acquired weakness
  di: Yuichi Akama, et al.
  Pubblicazione: (2024)